Barclays (LON:BARC) analyst Steven Valiquette maintained a Buy rating on Cigna Corp (NYSE:CI) on Friday, setting a price target of $260, which is approximately 18.78% above the present share price of $218.9.
Valiquette expects Cigna Corp to post earnings per share (EPS) of $3.81 for the first quarter of 2021.
The current consensus among 14 TipRanks analysts is for a Strong Buy rating of shares in Cigna, with an average price target of $258.21.
The analysts price targets range from a high of $280 to a low of $229.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $40.98 billion and a net profit of $0. The company's market cap is $79.08 billion.
According to TipRanks.com, Barclays analyst Steven Valiquette is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 3.1% and a 56.82% success rate.
Cigna Corp. engages in the provision of global health services. It operates through the following segments: Health Services, Integrated Medical, International Markets, and Group Disability and Other. The Health Services segment includes pharmacy benefits management, specialty pharmacy services, clinical solutions, home delivery, and health management services. The Integrated Medical segment offers a variety of health care solutions to employers and individuals. The International Markets segment covers supplemental health, life and accident insurance products; and health care coverage in its international markets as well as health care benefits to globally mobile employees of multinational organizations. The Group Disability and Other segment represents group disability and life, corporate-owned life insurance, and run-off business consisting of reinsurance; settlement authority; and individual life insurance and annuity and retirement benefits business. The company was founded in 1792 and is headquartered in Bloomfield, CT.